|
Q2 FY2026
As of Jun 30, 2026
|
Q1 FY2026
As of Mar 31, 2026
|
Q4 FY2025
As of Dec 31, 2025
|
Q3 FY2025
As of Sep 30, 2025
|
Q2 FY2025
As of Jun 30, 2025
|
Q1 FY2025
As of Mar 31, 2025
|
Q4 FY2024
As of Dec 31, 2024
|
Q3 FY2024
As of Sep 30, 2024
|
Q2 FY2024
As of Jun 30, 2024
|
Q1 FY2024
As of Mar 31, 2024
|
Q4 FY2023
As of Dec 31, 2023
|
Q3 FY2023
As of Sep 30, 2023
|
Q2 FY2023
As of Jun 30, 2023
|
Q1 FY2023
As of Mar 31, 2023
|
Q4 FY2022
As of Dec 31, 2022
|
Q3 FY2022
As of Sep 30, 2022
|
Q2 FY2022
As of Jun 30, 2022
|
Q1 FY2022
As of Mar 31, 2022
|
Q4 FY2021
As of Dec 31, 2021
|
Q3 FY2021
As of Sep 30, 2021
|
|
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| ASSETS | ||||||||||||||||||||
| Cash and due from banks | ||||||||||||||||||||
| Interest-bearing deposits | ||||||||||||||||||||
| Total cash and cash equivalents | ||||||||||||||||||||
| Securities—trading | ||||||||||||||||||||
| Debt Securities, Available-for-Sale | ||||||||||||||||||||
| Securities—held-to-maturity, net of allowance for credit losses of $283 and $291, respectively | ||||||||||||||||||||
| Total securities | ||||||||||||||||||||
| Debt Securities, Available-for-Sale and Held-to-Maturity, after Allowance for Credit Loss, Total | ||||||||||||||||||||
| Federal Home Loan Bank (FHLB) stock | ||||||||||||||||||||
| Securities purchased under agreements to resell | ||||||||||||||||||||
| Loans held for sale (includes $17,139 and $34,586, at fair value, respectively) | ||||||||||||||||||||
| Loans receivable | ||||||||||||||||||||
| Financing Receivable, before Allowance for Credit Loss | ||||||||||||||||||||
| Financing Receivable, Allowance for Credit Loss | ||||||||||||||||||||
| Net loans receivable | ||||||||||||||||||||
| Accrued interest receivable | ||||||||||||||||||||
| Property and equipment, net | ||||||||||||||||||||
| Goodwill | ||||||||||||||||||||
| Other intangibles, net | ||||||||||||||||||||
| Bank-owned life insurance (BOLI) | ||||||||||||||||||||
| Deferred tax assets, net | ||||||||||||||||||||
| Operating lease right-of-use assets | ||||||||||||||||||||
| Other assets | ||||||||||||||||||||
| Total assets | ||||||||||||||||||||
| LIABILITIES | ||||||||||||||||||||
| Deposits: | ||||||||||||||||||||
| Non-interest-bearing accounts | ||||||||||||||||||||
| Regular savings accounts | ||||||||||||||||||||
| Interest-bearing certificates | ||||||||||||||||||||
| Total deposits | ||||||||||||||||||||
| Advances from FHLB | ||||||||||||||||||||
| Other borrowings | ||||||||||||||||||||
| Subordinated notes, net | ||||||||||||||||||||
| Junior subordinated debentures at fair value (issued in connection with Trust Preferred Securities) | ||||||||||||||||||||
| Operating lease liabilities | ||||||||||||||||||||
| Accrued expenses and other liabilities | ||||||||||||||||||||
| Deferred compensation | ||||||||||||||||||||
| Total liabilities | ||||||||||||||||||||
| SHAREHOLDERS’ EQUITY | ||||||||||||||||||||
| Preferred stock - $0.01 par value per share, 500,000 shares authorized; no shares outstanding at June 30, 2026 and December 31, 2025 | ||||||||||||||||||||
| Common stock and paid in capital | ||||||||||||||||||||
| Voting Common Stock | ||||||||||||||||||||
| Nonvoting Common Stock | ||||||||||||||||||||
| Retained earnings | ||||||||||||||||||||
| Carrying value of shares held in trust for stock-based compensation plans | ||||||||||||||||||||
| Liability for common stock issued to stock related compensation plans | ||||||||||||||||||||
| Accumulated other comprehensive loss | ||||||||||||||||||||
| Total shareholders’ equity | ||||||||||||||||||||
| Total liabilities and shareholders’ equity | ||||||||||||||||||||
Loading...
